Rolf Doerr

ORCID: 0000-0002-6599-2958
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiovascular Function and Risk Factors
  • Cardiac, Anesthesia and Surgical Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Colorectal and Anal Carcinomas
  • Gastrointestinal disorders and treatments
  • Nonmelanoma Skin Cancer Studies
  • Cardiac electrophysiology and arrhythmias
  • Biliary and Gastrointestinal Fistulas
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Cerebrovascular and Carotid Artery Diseases
  • Intestinal and Peritoneal Adhesions
  • Chemotherapy-related skin toxicity
  • Electrolyte and hormonal disorders
  • Cardiac Arrest and Resuscitation
  • Diabetes Management and Research
  • Cancer and Skin Lesions
  • Vascular Procedures and Complications
  • Colorectal Cancer Surgical Treatments
  • Cardiovascular Disease and Adiposity
  • Colorectal Cancer Treatments and Studies
  • Diverticular Disease and Complications

Orthopädische Praxis
2011-2024

New York University
2021

Praxis
2011-2020

NYU Langone Health
2020

RWTH Aachen University
1988-1992

Westfälische Hochschule
1992

KU Leuven
1991

To evaluate the diagnostic usefulness of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) in patients primary colorectal carcinomas.Forty-eight biopsy-proved (n = 44) or high clinical suspicion for 4) cancer underwent whole-body PET after intravenous administration 10 mCi (370 MBq) FDG. FDG results were correlated computed tomographic (CT), surgical, and histopathologic findings.PET depicted all known intraluminal carcinomas 37 (including two situ carcinomas)...

10.1148/radiology.206.3.9494497 article EN Radiology 1998-03-01
Judith S. Hochman Rebecca Anthopolos Harmony R. Reynolds Sripal Bangalore Yifan Xu and 95 more Sean M. O’Brien Stavroula Mavromichalis Michelle Chang Aira Contreras Yves Rosenberg Ruth Kirby Balram Bhargava Roxy Senior Ann Banfield Shaun G. Goodman Renato D. Lópes Radosław Pracoń José López‐Sendón Aldo P. Maggioni Jonathan Newman Jeffrey S. Berger Mandeep S. Sidhu Harvey D. White Andrea B. Troxel Robert A. Harrington William E. Boden Gregg W. Stone Daniel B. Mark John A. Spertus David J. Maron Judith S. Hochman David J. Maron Harmony R. Reynolds Sripal Bangalore Stavroula Mavromichalis Michelle Chang Aira Contreras Shari Esquenazi‐Karonika Margaret Gilsenan Ewelina Gwiszcz Patenne D. Mathews Samaa Mohamed Anna K. Naumova Arline Roberts Kerrie VanLoo Rebecca Anthopolos Yifan Xu Andrea B. Troxel Ying Lü Zhen Huang Samuel Broderick Luis A. Guzmán Joseph B. Selvanayagam Renato D. Lópes Shaun G. Goodman Philippe Gabríel Steg Jean‐Michel Juliard Rolf Doerr Matyàs Keltai Balram Bhargava Boban Thomas Tali Sharir Eugenia Nikolsky Aldo P. Maggioni Shun Kohsaka Jorge Escobedo Harvey D. White Radosław Pracoń O.L. Bockeria José López‐Sendón Claes Held Roxy Senior Ann Banfield Leslee J. Shaw Lawrence M. Phillips Daniel S. Berman Raymond Y. Kwong Michael H. Picard Bernard R. Chaitman Ziad A. Ali James K. Min G.B. John Mancini Jonathon Leipsic Luis A. Guzmán Graham S. Hillis S. Thambar Majo Joseph Joseph B. Selvanayagam John F. Beltrame Iréne Lang Herwig Schuchlenz Kurt Huber Kaatje Goetschalckx Whady Hueb Paulo Caramori Alexandre de Quadros Paola Smanio Cláudio Tinoco Mesquita Renato D. Lópes João V. Vítola

The ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) compared an initial invasive versus conservative management strategy for patients with chronic coronary disease moderate or severe ischemia, no major difference in most outcomes during a median 3.2 years. Extended follow-up mortality is ongoing.

10.1161/circulationaha.122.062714 article EN Circulation 2022-11-06

Background: Whether an initial invasive strategy in patients with stable ischemic heart disease and at least moderate ischemia improves outcomes the setting of a history failure (HF) or left ventricular dysfunction (LVD) when ejection fraction is ≥35% but <45% unknown. Methods: Among 5179 participants randomized into ISCHEMIA (International Study Comparative Health Effectiveness With Medical Invasive Approaches), all whom had (LVEF) ≥35%, we compared cardiovascular by treatment HF/LVD...

10.1161/circulationaha.120.050304 article EN Circulation 2020-08-29
Gregg W. Stone Ziad A. Ali Sean M. O’Brien Grace L. Rhodes Philippe Généreux and 95 more Sripal Bangalore Kreton Mavromatis Jennifer Horst Ovidiu Dressler Kian Keong Poh Ranjit Kumar Nath Nagaraja Moorthy Adam Witkowski Sudhanshu Kumar Dwivedi O.L. Bockeria Jiyan Chen Paola Smanio Michael H. Picard Bernard R. Chaitman Daniel S. Berman Leslee J. Shaw William E. Boden Harvey D. White Stephen E. Fremes Yves Rosenberg Harmony R. Reynolds John A. Spertus Judith S. Hochman David J. Maron William E. Boden Robert A. Harrington David O. Williams Karen P. Alexander Jeffrey S. Berger Daniel B. Mark Christie M. Ballantyne Rafael Beyar Balram Bhargava Chris Buller Antônio Carlos Carvalho Rafael Díaz Rolf Doerr Vladimír Džavík Shaun G. Goodman Gilbert Gosselin Rory Hachamovitch Christian W. Hamm Claes Held Malte Helm Kurt Huber Lixin Jiang Matyàs Keltai Shun Kohsaka Iréne Lang Renato D. Lópes José López‐Sendón Aldo P. Maggioni John Mancini C. Noel Bairey Merz James K. Min Eric D. Peterson Witold Rużyłło Joseph B. Selvanayagam Roxy Senior Tali Sharir Philippe Gabríel Steg Hanna Szwed Frans Van de Werf William S. Weintraub Harvey White Karen J. Calfas Mary Ann Champagne Michael Davidson Jerome L. Fleg Peter A. McCullough Jonathan Newman Peter Stone Philippe Menasché Michael Davidson Stephen E. Fremes Robert A. Guyton Michael J. Mack Fred Mohr Anupama Rao Joe Sabik Oz M. Shapira David P. Taggart James Tatoulis Jim Blankenship Sorin J. Brener Chris Buller Antonio Colombo Bernard De Bruyne Dean J. Kereiakes Thierry Lefévre Jeffrey W. Moses Karen P. Alexander K. W. Mahaffey Harvey White Salvador Cruz‐Flores

10.1016/j.jacc.2023.06.015 article EN publisher-specific-oa Journal of the American College of Cardiology 2023-07-17

Background: Among patients with diabetes and chronic coronary disease, it is unclear if invasive management improves outcomes when added to medical therapy. Methods: The ISCHEMIA (International Study of Comparative Health Effectiveness Medical Invasive Approaches) trials (ie, ISCHEMIA–Chronic Kidney Disease) randomized disease an (medical therapy + angiography revascularization feasible) or a conservative approach alone failed). Cohorts were combined after no trial-specific effects observed....

10.1161/circulationaha.121.054439 article EN Circulation 2021-09-15

In 42 patients with acute anterior myocardial infarction (AMI), we studied the course of Q-wave development and R-wave reduction during first 48 hours after onset chest pain. We used precordial mapping in relation to clinical features, hemodynamic measurements enzyme release. Q waves developed within 6-14 (mean 9 hours) symptoms. amplitudes demonstrated nearly a reflected image: They reduced abruptly 5-11 pain, coinciding ST-segment elevation. 14 (group A, 33%) initial QRS alterations, there...

10.1161/01.cir.62.2.266 article EN Circulation 1980-08-01

Background: Patients with significant (≥50%) left main disease (LMD) have a high risk of cardiovascular events, and guidelines recommend revascularization to improve survival. However, the impact intermediate LMD (stenosis, 25%–49%) on outcomes is unclear. Methods: Randomized ISCHEMIA (International Study Comparative Health Effectiveness With Medical Invasive Approaches) participants who underwent coronary computed tomography angiography at baseline were categorized into those (25%–49%)...

10.1161/circinterventions.121.010925 article EN Circulation Cardiovascular Interventions 2022-04-01

The value of the Selvester and Cardiac Infarction Injury Scores was assessed in a randomized, placebo-controlled study intravenous recombinant tissue plasminogen activator (rt-PA) 721 patients with acute myocardial infarction. Electrocardiograms (ECG) obtained at admission, 6 h 10 to 22 days after start therapy were analysed. Patients prior infarction or QRS duration ≧ 120 ms excluded, leaving 322 rt-PA group 333 placebo group. Cumulative 72-h release alpha-hydroxybutyrate dehydrogenase...

10.1093/oxfordjournals.eurheartj.a059905 article EN European Heart Journal 1991-03-01
Harmony R. Reynolds Courtney Page Leslee J. Shaw Daniel S. Berman Bernard R. Chaitman and 95 more Michael H. Picard Raymond Y. Kwong James K. Min Jonathon Leipsic G.B. John Mancini Matthew J. Budoff Cameron Hague Roxy Senior Hanna Szwed Balram Bhargava Jelena Čelutkienė Milind Gadkari Kevin R. Bainey Rolf Doerr Rúben Ramos Peter Ong Sudhir Naik Philippe Gabríel Steg Kaatje Goetschalckx Benjamin J.W. Chow Marielle Scherrer‐Crosbie Lawrence Phillips Daniel B. Mark John A. Spertus Karen P. Alexander Sean M. O’Brien William E. Boden Sripal Bangalore Gregg W. Stone David J. Maron Judith S. Hochman Kreton Mavromatis Jason Linefsky Todd Q. Miller Subhash Banerjee Jonathan Newman Robert Donnino Muhamed Sarić Khaled Abdul-Nour Peter Stone James J. Jang Gennie Yee Steven Weitz Suzanne V. Arnold O. Henry Michael D. Shapiro Steven Fein Mikhail Torosoff Radmila Lyubarova Sulagna Mookherjee Krzysztof Drzymalski Edward O. McFalls Santiago García Stefan Bertog Rizwan A. Siddiqui Areef Ishani Ronnell A. Hansen Michel G. Khouri Jonathan Goldberg Richard S. Goldweit Ronny Cohen Brooks Mirrer Victor J. Navarro David E. Winchester Marvin W. Kronenberg Christopher McFarren John F. Heitner Ira Dauber Charles R. Cannan Sriram Sudarshan Puja K. Mehta Michael McDaniel Stamatios Lerakis Arshed A. Quyyumi Nanette K. Wenger Chester M. Hedgepeth Heather Hurlburt Alan Rosen Zakir Sahul Steve Leung Hassan Reda Khaled M. Ziada Sampoornima Setty Rajat S. Barua Fadi G. Hage James E. Davies Massoud A. Leesar Jaekyeong Heo Amy Iskandrian Firas Al Solaiman Satinder P. Singh Khaled Dajani Mohammad El‐Hajjar Paul Der Mesropian Joseph Sacco

BACKGROUND: The relationship between the extent and severity of stress-induced ischemia anatomic coronary artery disease (CAD) in patients with obstructive CAD is multifactorial includes intensity stress achieved, type testing used, presence prior infarction, collateral blood flow, plaque characteristics, microvascular disease, vasomotor tone, genetic factors. Among chronic participants site-determined moderate or severe ischemia, we investigated associations on computed tomography...

10.1161/circinterventions.123.013743 article EN Circulation Cardiovascular Interventions 2024-12-01

Background The long-term outcome of impaired regional myocardial contractility after successful single vessel percutaneous transluminal coronary angioplasty (PTCA) was angiographically evaluated. Methods ventriculograms prior to PTCA and at mid-term follow-up 250 consecutive patients with elective single-vessel were analyzed. One hundred demonstrated wall motion abnormalities in the vessel-dependent region by visual analysis before PTCA. study group comprised 66 these 100 (four women, 62...

10.1097/00019501-199206000-00007 article EN Coronary Artery Disease 1992-06-01
Coming Soon ...